~/talk

AI for the Proper Use of Medications

TalkinFrenchat Devoxx France 2022 · 2022-04-20..04-22· [machine-learning]
links:none on file
links:none on file
slides:none on file

Vidal built a Data Science platform to semi‑automatically extract drug indications, contraindications and adverse effects from about 10,000 RCP documents using 19 years of pharmacist annotations, producing roughly 10,000 deep models (≈20k including similarity models) and reaching 85–90% F1. Extraction uses CamemBERT with convolutional heads for transfer learning, a Ratcliff‑Obershelp string similarity method and rule‑based postprocessing; pharmacists validate monthly suggestions through a UI and CI/CD plus retraining are orchestrated with Airflow, Jenkins, S3, DVC and Kubernetes with continuous feedback into the knowledge base.

AI-written summary · about

  1. 0:00Introduction
  2. 0:49THE MEDICINE IS NOT A PRODUCT LIKE ANY OTHER
  3. 2:09Assistance for proper medication use
  4. 3:38Exploiting knowledge
  5. 5:52Concept extraction
  6. 7:47Automatic concept extraction
  7. 8:07The project
  8. 9:24The feature team
  9. 9:49Learning database
  10. 10:32Extraction algorithms
  11. 11:11Similarity-based approach
  12. 15:56BERT: Transfer Learning
  13. 16:58Embeddings
  14. 21:21Training dataset
  15. 23:40Convolution
  16. 25:44Common denominator
  17. 26:57K Class CommonDenominator Model
  18. 27:40Business rules method
  19. 28:38Hybrid method: An RCP annotation
  20. 29:30How many models?
  21. 30:08Evaluation
  22. 30:39The Data Science platform with the pipeline and feedback loop
  23. 44:09DEVOX France
~/search
type to search 6,249 conferences, 138,987 speakers and 185,172 talks
~/help
cmdctrl k
search every conference, speaker and series
/
focus the filter search
h
home
c
conferences
s
speakers
e
series
t
light / dark — the status bar button does the same
?
this help
esc
close this, then clear every filter — or just the search, while you are typing in it

Ignored while you are typing. Pages without a filter rail have no search to focus.